Cargando…

Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant

The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilmjärv, Sten, Abdul, Fabien, Acosta-Gutiérrez, Silvia, Estarellas, Carolina, Galdadas, Ioannis, Casimir, Marina, Alessandrini, Marco, Gervasio, Francesco Luigi, Krause, Karl-Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249556/
https://www.ncbi.nlm.nih.gov/pubmed/34210996
http://dx.doi.org/10.1038/s41598-021-91662-w
_version_ 1783716920889966592
author Ilmjärv, Sten
Abdul, Fabien
Acosta-Gutiérrez, Silvia
Estarellas, Carolina
Galdadas, Ioannis
Casimir, Marina
Alessandrini, Marco
Gervasio, Francesco Luigi
Krause, Karl-Heinz
author_facet Ilmjärv, Sten
Abdul, Fabien
Acosta-Gutiérrez, Silvia
Estarellas, Carolina
Galdadas, Ioannis
Casimir, Marina
Alessandrini, Marco
Gervasio, Francesco Luigi
Krause, Karl-Heinz
author_sort Ilmjärv, Sten
collection PubMed
description The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant.
format Online
Article
Text
id pubmed-8249556
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82495562021-07-06 Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant Ilmjärv, Sten Abdul, Fabien Acosta-Gutiérrez, Silvia Estarellas, Carolina Galdadas, Ioannis Casimir, Marina Alessandrini, Marco Gervasio, Francesco Luigi Krause, Karl-Heinz Sci Rep Article The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant. Nature Publishing Group UK 2021-07-01 /pmc/articles/PMC8249556/ /pubmed/34210996 http://dx.doi.org/10.1038/s41598-021-91662-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ilmjärv, Sten
Abdul, Fabien
Acosta-Gutiérrez, Silvia
Estarellas, Carolina
Galdadas, Ioannis
Casimir, Marina
Alessandrini, Marco
Gervasio, Francesco Luigi
Krause, Karl-Heinz
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_full Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_fullStr Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_full_unstemmed Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_short Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_sort concurrent mutations in rna-dependent rna polymerase and spike protein emerged as the epidemiologically most successful sars-cov-2 variant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249556/
https://www.ncbi.nlm.nih.gov/pubmed/34210996
http://dx.doi.org/10.1038/s41598-021-91662-w
work_keys_str_mv AT ilmjarvsten concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT abdulfabien concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT acostagutierrezsilvia concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT estarellascarolina concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT galdadasioannis concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT casimirmarina concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT alessandrinimarco concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT gervasiofrancescoluigi concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT krausekarlheinz concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant